Cancer Etiopathogenesis: Integrating Pathology and Microbiology
Click to zoom
Medical

Cancer Etiopathogenesis: Integrating Pathology and Microbiology

2700
Professional Publication Services
978-93-5773-125-6
407 pages
Order via WhatsApp
Publisher
Professional Publication Services
ISBN
978-93-5773-125-6
Pages
407
Price
INR 2700
About this book

Overview

Cancer remains one of the most complex and challenging diseases in modern medicine. Despite significant advances in diagnostics, therapeutics, and molecular biology, the fundamental processes underlying cancer development continue to demand deeper exploration and integration across disciplines.
Cancer Etiopathogenesis: Integrating Pathology and Microbiology has been developed to provide a comprehensive and structured understanding of the causes and mechanisms of cancer. This book bridges the domains of pathology and microbiology, offering a unified perspective on genetic, environmental, chemical, physical, and infectious factors involved in carcinogenesis.
The text is organized into three major sections. The first section lays the foundational principles of cancer etiology, including genetic alterations, molecular mechanisms, and environmental influences. The second section focuses on physical and chemical carcinogens, exploring their mechanisms and clinical implications. The third section highlights the critical role of microbial agents—including viruses, bacteria, parasites, and the microbiome—in cancer development.
Special emphasis has been placed on clarity, conceptual depth, and integration of molecular mechanisms with clinical relevance. The inclusion of structured chapters and illustrative figures aims to enhance understanding for students, postgraduate trainees, and practicing clinicians.
We hope this book serves as a valuable resource for academic learning, research, and clinical application, and contributes to a deeper understanding of cancer biology.

About the Authors
01 Dr. Harish Dara
Dr. Harish Dara
Author
Dr. Harish Dara is a Consultant Surgical Oncologist with extensive experience in the comprehensive surgical management of solid organ malignancies. He specializes in head and neck cancers with reconstruction, oncoplastic breast surgery, Robotic and laparoscopic gastrointestinal and colorectal cancers, gynecological oncology, and complex cytoreductive surgeries including HIPEC. With over eleven years of focused oncology practice, Dr. Dara has been actively involved in managing advanced, recurrent, and high-risk cancers, often requiring multivisceral resections and multidisciplinary coordination. He has a particular interest in peritoneal surface malignancies, soft tissue sarcomas, and complex pelvic oncologic surgeries, and has successfully performed several long-duration, technically demanding procedures with favorable outcomes. Dr. Dara is deeply committed to evidence-based cancer care, surgical precision, and functional reconstruction, ensuring optimal oncologic clearance while prioritizing quality of life. He is also actively engaged in training young surgeons, surgical oncology education, and public cancer awareness initiatives. A strong advocate of multidisciplinary teamwork, Dr. Dara works closely with medical oncologists, anesthesiologists, critical care specialists, and allied teams to deliver holistic and patient-centered cancer care. His professional philosophy centers on ethical practice, surgical excellence, and compassionate care, with the ultimate goal of improving long-term outcomes for cancer patients.
02 Dr. Srinivasa Tejaswini Adada
Dr. Srinivasa Tejaswini Adada
Author
Dr. Srinivasa Tejaswini Adada is a distinguished Medical Oncologist, Hematologist, and Bone Marrow Transplant (BMT) Physician at Cancer Conscious Clinics. She specializes in precision oncology, translational cancer research, and advanced hematologic malignancy management, with a strong focus on integrating innovation into clinical cancer care. She is the Co-founder and Director of Cancer Conscious Clinics, Fifthcare Solutions, and MEDHIC.AI, where she leads the development of AI-driven oncology and digital health platforms aimed at enhancing diagnostic accuracy, optimizing therapeutic outcomes, and advancing personalized medicine. Her work represents a significant shift toward data-informed and technology-enabled cancer treatment paradigms. Dr. Tejaswini has undertaken advanced executive education in Healthcare Management and Innovation from the Indian School of Business (ISB), Oxford Saïd Business School, and the Cambridge Centre for Innovation and Development, equipping her with a rare blend of clinical expertise, strategic leadership, and healthcare innovation acumen. She is an active contributor to global oncology research and professional collaboration through her memberships in ESMO, ASCO, ISMPO, and ISBMT. Her multidisciplinary work spans clinical trial supervision, biomarker-driven research, immunotherapy innovations, and next-generation therapeutic strategies. Her current academic and clinical focus lies at the intersection of precision oncology, immunotherapy, and AI-enhanced diagnostic platforms, positioning her as a leader in technology-driven, evidence-based cancer care with the goal of improving patient outcomes through cutting-edge research and clinical excellence.
View All 5 Authors